PGM3 and myelodysplastic syndrome: The genetic diagnosis of our patient was fundamental not only in clarifying the underlying cause of her clinical presentation but also in guiding long-term management and surveillance strategies. PGM3 pathogenic variants have recently been associated with an increased risk of developing myelodysplastic syndrome, highlighting the need for careful hematological monitoring over time [13].